Meridian Bioscience Stock Net Income
| VIVODelisted Stock | USD 33.97 0.00 0.00% |
Meridian Bioscience fundamentals help investors to digest information that contributes to Meridian Bioscience's financial success or failures. It also enables traders to predict the movement of Meridian Stock. The fundamental analysis module provides a way to measure Meridian Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Meridian Bioscience stock.
Meridian |
Meridian Bioscience Company Net Income Analysis
Meridian Bioscience's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Meridian Bioscience Net Income | 42.46 M |
Most of Meridian Bioscience's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Meridian Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Meridian Bioscience reported net income of 42.46 M. This is 87.56% lower than that of the Health Care Equipment & Supplies sector and 75.47% lower than that of the Health Care industry. The net income for all United States stocks is 92.56% higher than that of the company.
Meridian Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Meridian Bioscience's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Meridian Bioscience could also be used in its relative valuation, which is a method of valuing Meridian Bioscience by comparing valuation metrics of similar companies.Meridian Bioscience is currently under evaluation in net income category among related companies.
Meridian Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 1.39 B | |||
| Shares Outstanding | 43.83 M | |||
| Shares Owned By Insiders | 1.34 % | |||
| Shares Owned By Institutions | 90.92 % | |||
| Number Of Shares Shorted | 4.24 M | |||
| Price To Earning | 19.81 X | |||
| Price To Book | 3.92 X | |||
| Price To Sales | 4.35 X | |||
| Revenue | 333.02 M | |||
| Gross Profit | 188.36 M | |||
| EBITDA | 72.02 M | |||
| Net Income | 42.46 M | |||
| Cash And Equivalents | 83.49 M | |||
| Cash Per Share | 1.91 X | |||
| Total Debt | 25 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 3.52 X | |||
| Book Value Per Share | 8.41 X | |||
| Cash Flow From Operations | 82.36 M | |||
| Short Ratio | 7.74 X | |||
| Earnings Per Share | 0.96 X | |||
| Price To Earnings To Growth | 1.33 X | |||
| Target Price | 34.0 | |||
| Number Of Employees | 690 | |||
| Beta | 0.23 | |||
| Market Capitalization | 1.49 B | |||
| Total Asset | 463.1 M | |||
| Retained Earnings | 36.09 M | |||
| Working Capital | 104.22 M | |||
| Current Asset | 126.79 M | |||
| Current Liabilities | 22.57 M | |||
| Z Score | 35.4 | |||
| Five Year Return | 3.78 % | |||
| Net Asset | 463.1 M |
About Meridian Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Meridian Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Meridian Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Meridian Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Meridian Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Meridian Bioscience's short interest history, or implied volatility extrapolated from Meridian Bioscience options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| CRM | Salesforce | |
| GOOG | Alphabet Inc Class C |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Meridian Stock
If you are still planning to invest in Meridian Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Meridian Bioscience's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |